CanSino Biologics, Inc. Class H (CJH) Income Statement
CanSino Biologics, Inc. Class H Income Statement
Last quarter (Q3 2026), CanSino Biologics, Inc. Class H's total revenue was $332.43M, an increase of 7.19% from the same quarter last year. In Q3, CanSino Biologics, Inc. Class H's net income was $17.01M. See CanSino Biologics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.03B | $ 846.34M | $ 345.18M | $ 1.03B | $ 4.30B | |
| $ 681.82M | $ 601.91M | $ -876.02M | $ -186.61M | $ 3.00B | |
| $ 794.94M | $ 958.80M | $ 1.16B | $ 1.18B | $ 1.20B | |
| Depreciation and Amortization | $ 174.10M | $ 211.38M | $ 269.05M | $ 196.36M | $ 88.54M |
| $ 60.98M | $ -163.84M | $ -1.65B | $ -1.30B | $ 1.87B | |
| $ -113.12M | $ -375.22M | $ -2.04B | $ -1.37B | $ 1.94B | |
| $ 134.30M | $ -5.98M | $ 56.30M | $ 184.74M | $ -4.01M | |
| $ 21.18M | $ -381.20M | $ -1.98B | $ -1.18B | $ 1.94B | |
| $ 27.15M | $ -378.88M | $ -1.48B | $ -909.43M | $ 1.91B | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.11 | $ -1.53 | $ -6.01 | $ -3.68 | $ 7.74 |
| Diluted EPS | $ 0.11 | $ -1.53 | $ -6.01 | $ -3.68 | $ 7.74 |
| Weighted Average Shares Outstanding | 253.38M | 247.64M | 246.77M | 247.02M | 247.45M |
| Weighted Average Shares Outstanding (Diluted) | 253.38M | 247.64M | 246.77M | 247.02M | 247.45M |
Currency in CNY
